Strategem Capital (TSXV:SGE) Research & Development: C$0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:SGE Strategem Capital Corp TSXV:SGE
47 GF Score
Price C$0.89
GF Value C$0.14
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Strategem Capital Research & Development?

Strategem Capital TSXV:SGE 47 Research & Development is C$0.00 Mil as of Jun. 2026. GuruFocus rates TSXV:SGE with a GF Score™ of 47/100 and a GF Value™ of C$0.14 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Strategem Capital's Research & Development for the three months ended in Jun. 2026 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was C$0.00 Mil.

Strategem Capital  (TSXV:SGE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Strategem Capital Research & Development Related Terms

Strategem Capital Research & Development Historical Data

* Premium members only.

The historical data trend for Strategem Capital's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Strategem Capital Research & Development Chart

Strategem Capital Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Strategem Capital Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSXV:SGE
47GF Score
Strategem Capital Corp TSXV:SGE
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Strategem Capital Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$0.00 Mil mean?
Strategem Capital (TSXV:SGE) has a Research & Development of C$0.00 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Strategem Capital and its competitors.
Is Strategem Capital's Research & Development too high?
Strategem Capital's current Research & Development is C$0.00 Mil. Overall, Strategem Capital has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Strategem Capital's Research & Development compare to BLK and BX?
Strategem Capital's Research & Development of C$0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Strategem Capital and its competitors. Strategem Capital's current Research & Development is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strategem Capital stock overvalued right now?
Based on GuruFocus' analysis, Strategem Capital (TSXV:SGE) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.14, compared to a current price of C$0.89 — trading 535.7% above its estimated fair value. The current Research & Development is C$0.00 Mil. Strategem Capital's overall GF Score™ is 47/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Strategem Capital (TSXV:SGE), the current Research & Development is C$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Strategem Capital (TSXV:SGE) Overvalued in 2026?

Based on GuruFocus' analysis, Strategem Capital stock appears to be overvalued. The current stock price of C$0.89 is trading 535.7% above its estimated GF Value™ of C$0.14. GuruFocus considers Strategem Capital to be Significantly Overvalued.

Key valuation signals for TSXV:SGE:

  • Research & Development: C$0.00 Mil
  • GF Value™: C$0.14 vs. price of C$0.89 (535.7% above fair value)
  • GF Score™: 47/100 with 1 warning sign

No single metric tells the full story. See the TSXV:SGE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Strategem Capital Business Description

Address 240 11 Avenue South West, Suite 210, Calgary, BC, CAN, T2R 0C3
Strategem Capital Corp invests in resource exploration and development opportunities, mining, energy production and agricultural protein products. Its investments are focused on high growth opportunities in private or public companies and its objective is to own and manage operating businesses. The company derives revenue in the form of interest, dividends and gains on the sale of investments.
47GF Score

Get the complete analysis for TSXV:SGE

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.89
Price
C$0.14
GF Value